10 results about "Chrysanthemum indicum" patented technology

This invention provides a combination of medicine and device for treating dental diseases. The method for preparing the medicine is as follows: Boil 1 dan (approximately 50 catties) of cocklebur root and stems, 30 jin (approximately 15 catties) of wild chrysanthemum stems and leaves, and 5 jin (approximately 2.5 kg) of licorice root in a pot until thoroughly cooked. Remove the dregs, and bring the remaining liquid to a boil over high heat, then simmer over low heat until it becomes a paste. When the paste is about 70% cooked, for the treatment of gingivitis and periodontitis, add 100g of indigo naturalis, 50g of mirabilite, 150g of borax, 100g of gypsum, and an appropriate amount of edible preservative. Set aside when fully cooked. For the treatment of toothache, when the paste is about 70% cooked, add 50g of asarum, 100g of angelica dahurica, 100g of Sichuan pepper, 50g of bee honeycomb, 50g of rosin, 100g of borax, 50g of gypsum, and an appropriate amount of edible preservative. (These herbs should be pulverized before being added.) Set aside when fully cooked. The treatment device is a long, narrow, isosceles trapezoid with a hollowed-out center and top base, leaving a wall thickness of 0.2-0.4 mm. The device's dimensions are: base 13 mm, sides 13 mm, and length 18 mm. It can be made of metal or non-toxic plastic. A strip of cloth of the corresponding size is attached to the device, and the prepared ointment is applied to the cloth. When using it, the ointment-coated device is placed on the affected area, ensuring close contact with the lesion and maximizing the medication's effectiveness.

This invention discloses a green control method for tomato viral diseases based on the synergistic effect of Solanaceae and Asteraceae weeds, belonging to the field of agricultural plant crop protection technology. This invention uses the Solanaceae weed *Solanum nigrum* and the Asteraceae weed *Chrysanthemum indicum* as indicator plants for tomato viral diseases. By arranging the indicator plants in a grid pattern, comprehensive monitoring of major viral disease species within the facility can be achieved. By monitoring the viral disease symptoms of the indicator plants, early warnings can be issued 7-10 days in advance, allowing more time for tomato disease control and improving the timeliness and proactivity of prevention and control. Furthermore, based on the warnings issued by the indicator plants, an extract of *Eupatorium fortunei*, an Asteraceae weed that has a significant inhibitory effect on tomato viral disease symptoms, is applied, thus constructing an integrated "monitoring-blocking" green control system, achieving early warning and efficient control of viral diseases.

This invention provides a yin-nourishing and blood-tonifying medicinal composition, its preparation method, and its application, belonging to the technical field of traditional Chinese medicine compositions. The active ingredients of this composition are prepared from the following raw materials in parts by weight: Astragalus membranaceus 2-3 parts, Angelica sinensis 12-18 parts, Crataegus pinnatifida 2-3 parts, Glycyrrhiza uralensis 2-5 parts, Chrysanthemum indicum 5-9 parts, Melon japonica 20-30 parts, Lemon 15-19 parts, Fine corn flour 2-3 parts, and Whole milk powder 40-44 parts, wherein the weight ratio of Angelica sinensis to Astragalus membranaceus is (6-9):1. The composition of this invention can be prepared into various oral preparations using conventional pharmaceutical processes. The preparation process is stable and controllable, suitable for industrial production. This composition possesses the effects of nourishing yin and blood, strengthening the spleen and promoting digestion, is safe with no toxic side effects, and has an excellent taste. It can be used to prepare drugs for treating and improving yin and blood deficiency syndromes, and has good clinical application and industrialization prospects.

This invention discloses a traditional Chinese medicine composition for the prevention and / or treatment of herpes and / or its complications. By weight, the composition comprises: 8-14 parts of Sophora flavescens, 5-11 parts of Bistorta officinalis, 9-15 parts of Rheum palmatum, 0.5-6 parts of Coptis chinensis, 1-7 parts of Forsythia suspensa, 1-7 parts of Taraxacum mongolicum, 1-7 parts of Viola yedoensis, 1-7 parts of Paeonia lactiflora, 1-7 parts of Paeonia suffruticosa, 1-7 parts of Gardenia jasminoides, 3-9 parts of Rehmannia glutinosa, 1-7 parts of Chrysanthemum indicum, 1-7 parts of Lonicera japonica, 1-7 parts of Atractylodes lancea, 0.5-6 parts of Phellodendron chinense, 0.5-1.5 parts of Cicadae periostracum, 2-8 parts of Smilax glabra, 1-7 parts of Anemarrhena asphodeloides, 1-7 parts of Ophiopogon japonicus, 0.5-6 parts of Alisma plantago-aquatica, and 1-7 parts of Gypsum fibrosum. The complications are pain and / or inflammation. This traditional Chinese medicine composition is safe, effective, and has a simple and efficient preparation method with controllable quality. It also exhibits significant analgesic and anti-inflammatory effects and can treat shingles and its sequelae.

The present application relates to the technical field of traditional Chinese medicine, and particularly relates to a traditional Chinese medicine composition and application thereof in preparation of an antiviral medicine. The present application comprises honeysuckle, stevia leaf, wild chrysanthemum, isatis leaf and osmanthus, and the traditional Chinese medicine composition obtained thereby contains rich plant microRNA, MIR2911, thereby playing a good antiviral effect. Moreover, due to the negative effect of a flavoring agent on active ingredients in a product, the present application improves the prescription, and on the basis of avoiding the addition of a flavoring agent and a preservative, the product of the prescription obtains a good taste and can maintain stable quality for several months.

This invention discloses a lung-nourishing Solomon's Seal Ointment, its preparation method, and its application, relating to the field of traditional Chinese medicine technology. The herbal composition comprises three herbs: Herb A, Herb B, and Herb C. Herb A includes Solomon's Seal, Lycium barbarum, Chrysanthemum indicum, Mulberry fruit, White peony root, Rehmannia glutinosa, Raw Chinese yam, Ziziphus jujuba peel, Moutan bark, and Poria cocos. Herb B includes Achyranthes bidentata, Polygonatum sibiricum (processed with wine), Ophiopogon japonicus, Adenophora stricta, Tangerine peel, Prepared licorice root, Astragalus membranaceus, and Anemarrhena asphodeloides. The lung-nourishing Solomon's Seal Ointment is prepared by combining Herbs A and B in the herbal composition, decocting them in water, filtering the filtrate, concentrating the liquid, adding Herb C to dissolve, and then simmering over low heat to form an ointment. This technical solution is applied to the treatment of chronic obstructive pulmonary disease (COPD), forming a multi-target, holistic conditioning system. It provides crucial synergistic value to Western medicine's strategy of simply controlling symptoms in improving chronic COPD symptoms and enhancing quality of life, thereby improving the quality of life for COPD patients.

Abstract: This invention discloses a traditional Chinese medicine composition (Da Zhuque Decoction) with multi-target antiviral and anti-inflammatory activities, its preparation method, and its application. The composition consists of the following raw materials in parts by weight: Alisma plantago-aquatica 2-4 parts, Prunus armeniaca 4-6 parts, Chrysanthemum indicum 4-6 parts, Artemisia annua 5-7 parts, Morus alba leaf 5-7 parts, Gypsum 5-7 parts, Poria cocos 7-9 parts, Scutellaria baicalensis 8-10 parts, Rehmannia glutinosa 8-10 parts, Plantago asiatica 11-13 parts, Taraxacum mongolicum 14-16 parts, and Glycyrrhiza uralensis 3-5 parts. This invention overcomes the limitations of traditional qualitative formulation of traditional Chinese medicines. By limiting the specific synergistic ratio of artemisinin and baicalin (1:2.5~3.0), it achieves highly efficient inhibition of respiratory viruses (IC50=12.5μg / mL) and significant downregulation of inflammatory factors (IL-6, TNF-α). Meanwhile, the preparation process of "plaster decoction first - licorice extraction alone" solves the problem of easy decomposition of heat-sensitive components, increasing the artemisinin retention rate to over 95%. This invention has a clear material basis, controllable quality, and is suitable for preparing drugs or health products for the prevention and treatment of viral pneumonia.

The application discloses application of a wild chrysanthemum essential oil effective component combination in preparation of a medicine for preventing and treating acute lung injury, and particularly relates to the technical field of biological medicines, wherein the wild chrysanthemum essential oil effective component comprises beta-farnesene, 4-terpenol, artemisia oil, wild chrysanthemum alcohol and carvomenthone, and in an acute lung injury model, the wild chrysanthemum essential oil effective component can significantly regulate the survival state of lung epithelial cells, improve the phenomenon of cell activity decline, and effectively maintain the stability of mitochondrial membrane potential (Delta Psi m). In an acute lung injury mouse model, the wild chrysanthemum essential oil effective component combination can significantly improve the pathological injury of lung tissue, and significantly inhibit the expression of inflammatory mediators in bronchoalveolar lavage fluid (BALF). In summary, the wild chrysanthemum essential oil effective component combination can be applied in preparation of an anti-acute lung injury medicine.

This invention discloses a *Chrysanthemum indicum* extract and its application in cosmetics, belonging to the field of cosmetic technology. The extract is a *Chrysanthemum indicum* polysaccharide that has undergone acetylation-fucosylation dual modification, prepared through water extraction and alcohol precipitation, enzymatic acetylation, and carbodiimide-mediated grafting of fucose. This targeted modified extract is then compounded with fructooligosaccharides, β-glucan, dipotassium glycyrrhizate derivatives, and asiaticoside to prepare a chitosan-algin bilayer structure for layered release microcapsule gel. The extract of this invention can target and regulate the skin's microecology, and the composition possesses anti-inflammatory, soothing, barrier-repairing, and slow-release effects, is gentle and non-irritating, and suitable for sensitive skin care. This invention solves the problems of weak targeting, single efficacy, and poor stability in traditional prebiotic cosmetics, with controllable process and promising application prospects.